| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700322 | Clinical Oncology | 2006 | 6 Pages |
Abstract
All patients with DCIS have potential benefit to gain from adjuvant radiotherapy. However, radiotherapy also has adverse effects and represents over-treatment from many women. Support should be given to current trials which are assessing endocrine treatment of DCIS, and whether radiotherapy can reasonably be omitted in lower risk disease.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J.W. Adlard, N.J. Bundred,